BSX
Boston Scientific Corporation
Platform & Compounding FCF
B
71.2 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
6.4%
-
Operating Margin Trend
+0.86 pp/yr
-
5yr Avg ROE
7.8%
-
5yr Share-Count CAGR
1.1%
-
5yr Revenue CAGR
15.2%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
12.9%
-
5yr FCF/NI Conversion
1.27x
-
Net Debt / EBITDA
2.03x
-
Interest Coverage (EBIT/Int)
10.70x
-
Altman Z-Score
3.03
Stability
Weight: 5%
C-
50
-
EPS Volatility (σ/μ)
0.88
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
7
4 of 5 gurus held; 3 added; 1 trimmed; 2 full exits.
- Holders
- 4
-1
- Avg Δ position
-
+222.7%
- New buys
- 0
- Full exits
- 2